|
3MQM
Crystal Structure of the Bromodomain of human ASH1L
Deposited 2010-04-28
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2438–2564(127 aa)
Fragment:BROMODOMAIN of human ASH1L (UNP RESIDUES 2438:2564)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.15M NaNO3
20% PEG3350
10% EtGly, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.54 Å
R-free 0.259
|
|
3MQM
Crystal Structure of the Bromodomain of human ASH1L
Deposited 2010-04-28
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2438–2564(127 aa)
Fragment:BROMODOMAIN of human ASH1L (UNP RESIDUES 2438:2564)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.15M NaNO3
20% PEG3350
10% EtGly, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.54 Å
R-free 0.259
|
|
3MQM
Crystal Structure of the Bromodomain of human ASH1L
Deposited 2010-04-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2438–2564(127 aa)
Fragment:BROMODOMAIN of human ASH1L (UNP RESIDUES 2438:2564)
Chain B
2438–2564(127 aa)
Fragment:BROMODOMAIN of human ASH1L (UNP RESIDUES 2438:2564)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.15M NaNO3
20% PEG3350
10% EtGly, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.54 Å
R-free 0.259
|
|
3OPE
Structural Basis of Auto-inhibitory mechanism of Histone methyltransferase
Deposited 2010-08-31
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2074–2293(220 aa)
Fragment:SET domain (UNP RESIDUES 2074-2293)
|
Not recorded
|
ZN ZINC ION × 3
SAM S-ADENOSYLMETHIONINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;291 K;Bistrisprofane, PEG, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 2.90 Å
R-free 0.299
|
|
3OPE
Structural Basis of Auto-inhibitory mechanism of Histone methyltransferase
Deposited 2010-08-31
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2074–2293(220 aa)
Fragment:SET domain (UNP RESIDUES 2074-2293)
|
Not recorded
|
ZN ZINC ION × 3
SAM S-ADENOSYLMETHIONINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;291 K;Bistrisprofane, PEG, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 2.90 Å
R-free 0.299
|
|
4YNM
ASH1L wild-type SET domain in complex with S-adenosyl methionine (SAM)
Deposited 2015-03-10
|
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2074–2293(220 aa)
Fragment:SET domain (UNP residues 2074-2293)
|
Not recorded
|
ZN ZINC ION × 3
SAM S-ADENOSYLMETHIONINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;PEG 3350, 20 mM Tris
|
Resolution 2.19 Å
R-free 0.278
|
|
4YNM
ASH1L wild-type SET domain in complex with S-adenosyl methionine (SAM)
Deposited 2015-03-10
|
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2074–2293(220 aa)
Fragment:SET domain (UNP residues 2074-2293)
|
Not recorded
|
ZN ZINC ION × 3
SAM S-ADENOSYLMETHIONINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;PEG 3350, 20 mM Tris
|
Resolution 2.19 Å
R-free 0.278
|
|
4YNP
ASH1L SET domain S2259M mutant in complex with S-adenosyl methionine (SAM)
Deposited 2015-03-10
|
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2074–2293(220 aa)
Fragment:SET domain (UNP residues 2074-2293)
|
Mutation:S2259M
|
ZN ZINC ION × 3
SAM S-ADENOSYLMETHIONINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;PEG 3350, 20 mM Tris
|
Resolution 2.90 Å
R-free 0.319
|
|
4YNP
ASH1L SET domain S2259M mutant in complex with S-adenosyl methionine (SAM)
Deposited 2015-03-10
|
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2074–2293(220 aa)
Fragment:SET domain (UNP residues 2074-2293)
|
Mutation:S2259M
|
ZN ZINC ION × 3
SAM S-ADENOSYLMETHIONINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;PEG 3350, 20 mM Tris
|
Resolution 2.90 Å
R-free 0.319
|
|
4YPE
ASH1L SET domain H2193F mutant in complex with S-adenosyl methionine (SAM)
Deposited 2015-03-12
|
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2074–2293(220 aa)
Fragment:SET domain (UNP residues 2074-2293)
|
Mutation:H2193F
|
ZN ZINC ION × 3
SAM S-ADENOSYLMETHIONINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;PEG 3350, 20 mM Tris
|
Resolution 2.20 Å
R-free 0.263
|
|
4YPE
ASH1L SET domain H2193F mutant in complex with S-adenosyl methionine (SAM)
Deposited 2015-03-12
|
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2074–2293(220 aa)
Fragment:SET domain (UNP residues 2074-2293)
|
Mutation:H2193F
|
ZN ZINC ION × 3
SAM S-ADENOSYLMETHIONINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;PEG 3350, 20 mM Tris
|
Resolution 2.20 Å
R-free 0.263
|
|
4YPU
ASH1L SET domain K2264L mutant in complex with S-adenosyl methionine (SAM)
Deposited 2015-03-13
|
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2074–2293(220 aa)
Fragment:SET domain (UNP residues 2074-2293)
|
Mutation:K2264L
|
ZN ZINC ION × 3
SAM S-ADENOSYLMETHIONINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;PEG 3350, 20 mm Tris
|
Resolution 2.60 Å
R-free 0.305
|
|
4YPU
ASH1L SET domain K2264L mutant in complex with S-adenosyl methionine (SAM)
Deposited 2015-03-13
|
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2074–2293(220 aa)
Fragment:SET domain (UNP residues 2074-2293)
|
Mutation:K2264L
|
ZN ZINC ION × 3
SAM S-ADENOSYLMETHIONINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;PEG 3350, 20 mm Tris
|
Resolution 2.60 Å
R-free 0.305
|
|
6AGO
Crystal structure of MRG15-ASH1L Histone methyltransferase complex
Deposited 2018-08-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2039–2293(255 aa)
|
Not recorded
|
SAM S-ADENOSYLMETHIONINE × 1
ZN ZINC ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;295 K;Ammonium Acetate
|
Resolution 3.10 Å
R-free 0.272
|
|
6AGO
Crystal structure of MRG15-ASH1L Histone methyltransferase complex
Deposited 2018-08-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
2039–2293(255 aa)
|
Not recorded
|
ZN ZINC ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;295 K;Ammonium Acetate
|
Resolution 3.10 Å
R-free 0.272
|
|
6INE
Crystal Structure of human ASH1L-MRG15 complex
Deposited 2018-10-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2026–2288(263 aa)
|
Not recorded
|
ZN ZINC ION × 3
SAM S-ADENOSYLMETHIONINE × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;277 K;0.1 M Tris-HCl pH 8.5, 20 % PEG 6000, 0.2 M Trimethylamine-N-oxide
|
Resolution 2.60 Å
R-free 0.237
|
|
6WZW
Ash1L SET domain in complex with AS-85
Deposited 2020-05-14
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2074–2293(220 aa)
|
Not recorded
|
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
SAM S-ADENOSYLMETHIONINE × 1
ZN ZINC ION × 3
UG7 N-{[3-(3-carbamothioylphenyl)-1-{1-[(trifluoromethyl)sulfonyl]piperidin-4-yl}-1H-indol-6-yl]methyl}azetidine-3-carboxamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;290 K;0.1 M HEPES pH 7.5, 30% PEG3350
|
Resolution 1.69 Å
R-free 0.206
|
|
6X0P
Ash1L SET domain Q2265A mutant in complex with AS-5
Deposited 2020-05-17
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2074–2293(220 aa)
|
Mutation:Q2265A
|
UK7 3-[6-(aminomethyl)-1-(2-hydroxyethyl)-1H-indol-3-yl]benzene-1-carbothioamide × 1
ZN ZINC ION × 3
SAM S-ADENOSYLMETHIONINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;290 K;0.1 M Tris pH 8.5, 0.2 M MgCl2, 30% PEG4000
|
Resolution 1.69 Å
R-free 0.213
|
|
6X0P
Ash1L SET domain Q2265A mutant in complex with AS-5
Deposited 2020-05-17
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
2074–2293(220 aa)
|
Mutation:Q2265A
|
UK7 3-[6-(aminomethyl)-1-(2-hydroxyethyl)-1H-indol-3-yl]benzene-1-carbothioamide × 1
ZN ZINC ION × 3
SAM S-ADENOSYLMETHIONINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;290 K;0.1 M Tris pH 8.5, 0.2 M MgCl2, 30% PEG4000
|
Resolution 1.69 Å
R-free 0.213
|
|
6X0P
Ash1L SET domain Q2265A mutant in complex with AS-5
Deposited 2020-05-17
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
2074–2293(220 aa)
|
Mutation:Q2265A
|
UK7 3-[6-(aminomethyl)-1-(2-hydroxyethyl)-1H-indol-3-yl]benzene-1-carbothioamide × 1
ZN ZINC ION × 3
SAM S-ADENOSYLMETHIONINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;290 K;0.1 M Tris pH 8.5, 0.2 M MgCl2, 30% PEG4000
|
Resolution 1.69 Å
R-free 0.213
|
|
6X0P
Ash1L SET domain Q2265A mutant in complex with AS-5
Deposited 2020-05-17
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
2074–2293(220 aa)
|
Mutation:Q2265A
|
UK7 3-[6-(aminomethyl)-1-(2-hydroxyethyl)-1H-indol-3-yl]benzene-1-carbothioamide × 1
ZN ZINC ION × 3
SAM S-ADENOSYLMETHIONINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;290 K;0.1 M Tris pH 8.5, 0.2 M MgCl2, 30% PEG4000
|
Resolution 1.69 Å
R-free 0.213
|
|
7Y0I
Solution structures of ASH1L PHD domain in complex with H3K4me2 peptide
Deposited 2022-06-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2584–2635(52 aa)
|
Not recorded
|
ZN ZINC ION × 2
|
SOLUTION NMR
NMR measurement conditions
pH 7.2;298 K;Ionic strength (raw mmCIF value) null;Pressure 1
NMR sample composition
50 mM sodium phosphate, 100 mM sodium chloride, 100 uM ZINC ION, 2.0 mM [U-100% 2H] DTT, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
50 mM sodium phosphate, 100 mM sodium chloride, 100 uM ZINC ION, 2.0 mM [U-100% 2H] DTT, 100% D2O | 100% D2O
|
Resolution not provided
|
|
8VLD
Crystal structure of Ash1L PHD finger in complex with histone H3K4me2
Deposited 2024-01-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
2584–2636(53 aa)
Chain B
2584–2636(53 aa)
|
Not recorded
|
ZN ZINC ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;1.6 M sodium citrate pH 6.5
|
Resolution 1.92 Å
R-free 0.249
|
|
8VLF
Crystal structure of Ash1L PHD finger in complex with histone H3K4me3
Deposited 2024-01-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
2584–2636(53 aa)
Chain B
2584–2636(53 aa)
|
Not recorded
|
ZN ZINC ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;1.6 M sodium citrate pH 6.5
|
Resolution 1.34 Å
R-free 0.188
|
|
8VLH
Crystal structure of Ash1L PHD-BAH domains
Deposited 2024-01-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2584–2839(256 aa)
Chain B
2584–2839(256 aa)
|
Not recorded
|
ZN ZINC ION × 4
SR STRONTIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;0.1 M Bis-Tris propane pH 10, 0.25 M strontium chloride, 0.01 M ammonium sulfate, and 25% PEG 8000
|
Resolution 2.40 Å
R-free 0.284
|